Interleukin inhibitors are a type of immune disorder drug used to treat a variety of conditions, including rheumatoid arthritis, psoriasis, and Crohn's disease. These drugs work by blocking the action of interleukins, which are proteins that play a role in inflammation and the body's immune response. Interleukin inhibitors can be used alone or in combination with other drugs to reduce inflammation and improve symptoms. The interleukin inhibitor market is a rapidly growing segment of the immune disorder drug market. It is expected to continue to grow as more treatments become available and as the demand for treatments for immune-related conditions increases. Some of the major companies in the interleukin inhibitor market include AbbVie, Amgen, Bristol-Myers Squibb, Eli Lilly, and Pfizer. These companies are actively researching and developing new treatments for immune-related conditions. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
